Targeting metabolic transformation for cancer therapy

Daniel Tennant, R Durán, E Gottlieb

Research output: Contribution to journalArticlepeer-review

779 Citations (Scopus)


Cancer therapy has long relied on the rapid proliferation of tumour cells for effective treatment. However, the lack of specificity in this approach often leads to undesirable side effects. Many reports have described various 'metabolic transformation' events that enable cancer cells to survive, suggesting that metabolic pathways might be good targets. There are currently several drugs under development or in clinical trials that are based on specifically targeting the altered metabolic pathways of tumours. This Review highlights pathways against which there are already drugs in different stages of development and also discusses additional druggable targets.
Original languageEnglish
Pages (from-to)267-277
Number of pages11
JournalNature Reviews Cancer
Issue number4
Publication statusPublished - 1 Apr 2010


Dive into the research topics of 'Targeting metabolic transformation for cancer therapy'. Together they form a unique fingerprint.

Cite this